Cargando…
Esomeprazole- or rabeprazole-based triple therapy eradicated Helicobacter pylori comparably regardless of clarithromycin susceptibility and CYP2C19 genotypes
The aim of this study was to assess the efficacy of esomeprazole-based triple therapy compared with rabeprazole-based triple therapy according to CYP2C19 genotype and clarithromycin susceptibility status for first-line eradication therapy of Helicobacter pylori (H. pylori) in Japan. We enrolled 219...
Autores principales: | Okimoto, Tadayoshi, Mizukami, Kazuhiro, Ogawa, Ryo, Okamoto, Kazuhisa, Shuto, Mitsutaka, Fukuda, Kensuke, Kodama, Masaaki, Murakami, Kazunari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
the Society for Free Radical Research Japan
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018575/ https://www.ncbi.nlm.nih.gov/pubmed/27698544 http://dx.doi.org/10.3164/jcbn.16-18 |
Ejemplares similares
-
Analysis of long-term serological and histological changes after eradication of Helicobacter pylori
por: Fukuda, Kensuke, et al.
Publicado: (2022) -
Differences in Helicobacter pylori and CagA antibody changes after eradication between subjects developing and not developing gastric cancer
por: Kodama, Masaaki, et al.
Publicado: (2019) -
Objective Endoscopic Analysis with Linked Color Imaging regarding Gastric Mucosal Atrophy: A Pilot Study
por: Mizukami, Kazuhiro, et al.
Publicado: (2017) -
Differences in Regression Patterns of Complete and Incomplete Intestinal Metaplasia at Ten Years after Helicobacter pylori Eradication
por: Wada, Yasuhiro, et al.
Publicado: (2021) -
Differences in clinical features and morphology between differentiated and undifferentiated gastric cancer after Helicobacter pylori eradication
por: Kodama, Masaaki, et al.
Publicado: (2023)